Can-Fite BioPharma (CANF) EBT Margin (2015 - 2023)
Can-Fite BioPharma's EBT Margin was -2426.67% in FY2025, down 1257.53 percentage points from -1169.14% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) EBT Margin (2015 - 2023) Analysis & Trends
From FY2009 onward, Can-Fite BioPharma has reported EBT Margin for 13 years.
- EBT Margin shows a five-year change of -533.74 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual EBT Margin since FY2016.
- Per Business Quant data, EBT Margin in earlier years was -1169.14% in FY2024 (-141.68 pp), -1027.46% in FY2023 (+341.72 pp), -1369.18% in FY2022 (+109.72 pp) and -1478.90% in FY2021 (+414.02 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Can-Fite BioPharma | 1.36 Mn | -18.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -1,183.23% |
| Sep 30, 2023 | -951.53% |
| Jun 30, 2023 | -910.20% |
| Mar 31, 2023 | -1,383.67% |
| Dec 31, 2022 | -909.23% |
| Sep 30, 2022 | -1,261.27% |
| Jun 30, 2022 | -1,014.71% |
| Mar 31, 2022 | -1,156.10% |
| Dec 31, 2021 | -1,974.51% |
| Sep 30, 2021 | -1,398.41% |
| Jun 30, 2021 | -1,253.20% |
| Mar 31, 2021 | -1,466.89% |
| Dec 31, 2020 | -2,368.67% |
| Sep 30, 2020 | -1,174.88% |
| Jun 30, 2020 | -1,877.94% |
| Dec 31, 2019 | -1,440.63% |
| Sep 30, 2019 | -167.71% |
| Jun 30, 2019 | -1,661.95% |
| Mar 31, 2019 | 525.75% |
| Dec 31, 2018 | -1,481.31% |
API Access
Can-Fite BioPharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();